eOPN3‑Drug‑Resistant Epilepsy
Drug‑Resistant Epilepsy
PreclinicalActive
Key Facts
About Modulight Bio
Israeli optogenetics biotech leveraging light‑controlled GPCRs to treat refractory neurological disorders.
View full company profileTherapeutic Areas
Other Drug‑Resistant Epilepsy Drugs
| Drug | Company | Phase |
|---|---|---|
| Minder iCEM | Epiminder | Phase 2 |